Amprion Newsroom
Recent media coverage and announcements.
News Article
Technology Networks
Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
8/1/2024
Read MorePress Release
PR Newswire
Amprion's αSyn Seed Amplification Assay (αS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference
3/4/2024
Read MoreVideo
Neurology Live
Revolutionizing Multiple System Atrophy Diagnosis With Amprion's Synuclein Seed Amplification Assay: Russell Lebovitz MD PhD
12/18/2024
Read MoreVideo
Neurology Live
Detecting Parkinson Disease at Early Stages With Alpha-Synuclein Amplification Assay: Russell Lebovitz MD PhD
5/11/2023
Read MorePress Release
Mayo Clinic Laboratories News
Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics
3/26/2025
Read MorePress Release
Businesswire
Amprion Honored to Win the 2024 BioTech Breakthrough Award 'Clinical Diagnostics Solution of the Year'
11/19/2024
Read MorePress Release
Businesswire
Amprion Announces Landmark Study in The Lancet Neurology
11/21/2024
Read MorePress Release
PR Web
SYNTap Biomarker Test helps doctors distinguish Parkinson's Disease from Parkinsonism in early stages
4/6/2022
Read MorePress Release
PR Newswire
New Paper Published in Alzheimer's: Dementia: The Journal of the Alzheimer's Association Demonstrates Correlation Between the Presence of Misfolded α-Synuclein and Clinical Presentations of Alzheimer's Disease
2/9/2024
Read MorePress Release
PR Web
New Insights On Alzheimer's And What It Means For Personalized Medicine
1/19/2022
Read MorePress Release
PR Newswire
Amprion's αSynuclein Seed Amplification Assay to be Showcased at Alzheimer's Association International Conference® 2023 (AAIC®)
7/15/2023
Read MorePress Release
Business Wire
FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion's First Commercial Test
9/5/2024
Read MorePress Release
PR Newswire
Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson's Disease
5/30/2024
Read MorePress Release
Business Wire
Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
7/26/2024
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-É‘SYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
